Here, our results demonstrated that DHM exposure led to induction of autophagic cell death through modulation of the MALAT1/TFEB pathway in A431 cells, and provided experimental evidence to support the future development of DHM as an effective and safe candidate agent for the prevention and/or therapy of CSCC. The gene discussed is TFEB; the disease is skin squamous cell carcinoma.